SpaceX is working toward a Saturday, Oct. 25, launch of its Falcon 9 rocket from Vandenberg in Santa Barbara County. SpaceX will launch its famous two-stage 230-foot Falcon 9 rocket, one of the ...

SpaceX is working toward a Saturday, Oct. 18, launch of its Falcon 9 rocket from the Vandenberg Space Force Base in Santa Barbara County. The launch, a mission to deploy Starlink satellites for Elon ...

Shares of Rocket Lab Corp. shot up into record territory Friday, lifted by a deal to launch satellites for Japan’s space agency. The two-launch contract with the Japan Aerospace Exploration Agency ...

Rocket launch enthusiasts who enjoy watching giant spacecraft thunder into the sky from Southern California are in luck: SpaceX has potentially three missions within the next week scheduled to get off ...

Shares of Rocket Lab Corp (NASDAQ:RKLB) are trading higher Monday morning after Morgan Stanley significantly raised its price target and compared the company to SpaceX. Here’s what investors need to ...

Rocket Lab announced a new three-launch deal with iQPS -- on top of the four it already had planned. This deal occurs just one week after the company added 10 launches to a previous agreement with ...

Rocket Lab (NASDAQ: RKLB) has soared over 500% this year, and its upcoming Neutron rocket could send the stock even higher. With new defense contracts, government backing, and strong execution, Rocket ...

Rocket Lab USA (NASDAQ:RKLB) shot up in early trading after the company announced it has signed another multi-launch deal with Institute for Q-shu Pioneers of Space, Inc. The contract will see Rocket ...

A SpaceX Falcon 9 rocket is scheduled to launch from Cape Canaveral, Florida, with internet satellites on board. The rocket will carry 24 Project Kuiper broadband satellites into low-Earth orbit. Live ...

Starlink missions, by far the most common from California, can be widely seen across the region and even sometimes in Arizona. Postponements due to weather or issues with rockets are common with ...

Oct 3 (Reuters) - Rocket Pharmaceuticals (RCKT.O), opens new tab said on Friday it has withdrawn its application for U.S. approval of its experimental gene therapy for a rare inherited blood disorder.